Decoy Therapeutics Inc. logo

Decoy Therapeutics (DCOY) stock

DCOY · Decoy Therapeutics Inc. · NASDAQ

Market cap
$2.0M
Shares out
2.4M

What is the latest news on DCOY stock?

13D/Gago
Amendment: SEC Form SCHEDULE 13G/A filed by Decoy Therapeutics Inc.

SCHEDULE 13G/A - Decoy Therapeutics Inc. (0001615219) (Subject)

All DCOY news

Are insiders buying or selling DCOY?

No DCOY insider has reported a purchase or sale in the last 90 days. The last trade on file: Arnold C Hanish sold $17, reported on Jan 2, 2026.

DCOY insider trades

Financial highlights

Full financials
Net income, TTM
-$16.56M
Cash
$8.17M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

Latest news

25 items
News · 26 weeks510%
2026-05-24: 12026-05-31: 52026-06-07: 12026-06-14: 02026-06-21: 22026-06-28: 22026-07-05: 12026-07-12: 32026-07-19: 22026-07-26: 22026-08-02: 32026-08-09: 22026-08-16: 02026-08-23: 02026-08-30: 102026-09-06: 02026-09-13: 12026-09-20: 62026-09-27: 22026-10-04: 12026-10-11: 12026-10-18: 12026-10-25: 02026-11-01: 12026-11-08: 32026-11-15: 1
2026-05-242026-11-15
Mix2790d
  • Insider10(37%)
  • Other9(33%)
  • SEC Filings7(26%)
  • 13D/G1(4%)
Activity · 52 weeks7049 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Decoy Therapeutics Inc. (DCOY) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for DCOY, including 2 press releases and news items, 2 SEC filings and 1 13D/G filing. The most recent was published Nov 16, 2026.

DCOY FAQ

8 questions
  • Is DCOY profitable?
    No. Decoy Therapeutics Inc. reported a net loss of $16.56M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does DCOY have?
    Decoy Therapeutics Inc. reported $8.17M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does DCOY stock trade?
    Decoy Therapeutics Inc. (DCOY) is listed on NASDAQ.
  • What sector and industry is DCOY in?
    Decoy Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Decoy Therapeutics Inc. go public?
    Decoy Therapeutics Inc. (DCOY) completed its IPO in 2015.
  • What are analysts saying about DCOY?
    Decoy Therapeutics Inc. has had 1 recent analyst action on file. The most recent action was from Ladenburg Thalmann: Buy with a $2.50 price target on 2026-01-23. Recent price targets cluster around $2.50.
  • What companies are similar to DCOY?
    Notable peers in the same industry include JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), ABT (Abbott Laboratories), LLY (Eli Lilly and Company), NVO (Novo Nordisk A/S). Compare DCOY side-by-side with any of them on Quantisnow.
  • How can I track DCOY on Quantisnow?
    Quantisnow aggregates Decoy Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DCOY to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change